CHEMICAL AND SPECIAL STAIN REAGENTS (Notice of Intent To Sole Source)
ID: 36C25625R0069Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF256-NETWORK CONTRACT OFFICE 16 (36C256)RIDGELAND, MS, 39157, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/b538f8909c924a3a901a6f8ed174ec29/view
Timeline
  1. 1
    Posted Mar 6, 2025, 12:00 AM UTC
  2. 2
    Updated Mar 6, 2025, 12:00 AM UTC
  3. 3
    Due Apr 7, 2025, 9:00 PM UTC
Description

The Department of Veterans Affairs is issuing a Notice of Intent to Sole Source for the procurement of chemical and special stain reagents, which are critical for in-vitro diagnostic applications. This procurement aims to secure specific reagents necessary for laboratory testing and diagnostics within the Veterans Affairs healthcare system. The reagents play a vital role in ensuring accurate and timely medical assessments for veterans, thereby supporting their healthcare needs. Interested parties can reach out to James Hunt at james.hunt2@va.gov for further inquiries regarding this opportunity.

Point(s) of Contact
James Hunt
james.hunt2@va.gov
Files
No associated files provided.
Lifecycle
Title
Type
CHEMICAL AND SPECIAL STAIN REAGENTS (Notice of Intent To Sole Source)
Currently viewing
Special Notice
Similar Opportunities
Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
6640--FY 25 Short Term Emergency Contract Molecular Random Access Analyzer
Buyer not available
The Department of Veterans Affairs intends to award a sole-source contract to Cepheid for a Short Term Emergency procurement of a Molecular Random Access Analyzer, specifically the Cepheid GeneXpert Infinity Reagents and Consumables. This procurement is conducted under FAR 13.5 Simplified Procedures for Certain Commercial Items, emphasizing the need for efficient acquisition of critical laboratory equipment. The selected vendor must demonstrate technical capability to meet the government's requirements, with responses due by January 17, 2025, at 2:00 PM Eastern Time. Interested parties should submit their technical packages to Contract Specialist Darrin Alexander at darrin.alexander2@va.gov, noting that the government will not compensate for the information provided.
6640--CPRR - Cobas ROCHE REAGENTS/CONSUMABLES - BASE+4, Cinci
Buyer not available
The Department of Veterans Affairs is soliciting quotes for the acquisition of Roche Diagnostics Cobas 5800 System reagents and consumables for the Cincinnati VA Medical Center. This Request for Quote (RFQ) aims to establish a firm-fixed price contract for a base year plus four option years, focusing on enhancing testing efficiency for various infectious diseases, including HCV, HIV, and HPV. The procurement encompasses the provision of a molecular testing instrument, necessary reagents, consumables, and associated services such as installation, validation, and training, all while ensuring compliance with FDA-approved assays and connectivity with existing medical information systems. Interested bidders must submit their quotes by April 29, 2025, and can direct inquiries to Contract Specialist Alice Clark at alice.clark@va.gov.
6550-- Cancer Diagnosis Probes
Buyer not available
The Department of Veterans Affairs is soliciting proposals for cancer diagnosis probes under solicitation number 36C26225Q0840, aimed at enhancing diagnostic capabilities within the VA healthcare system. This procurement seeks specific, validated probes and reagents necessary for next-generation sequence testing, particularly for hematological disorders and solid tumors, reflecting the VA's commitment to improving patient care through advanced medical technology. Interested vendors must submit their quotations by May 2, 2025, with delivery scheduled from May 9, 2025, to May 8, 2026, to the VA Greater Los Angeles Healthcare System. For inquiries, vendors can contact Carlos Magana at carlos.magana@va.gov or by phone at 562-766-2253.
R602--Courier Specimen Transport Services
Buyer not available
The Department of Veterans Affairs, specifically the Network Contracting Office 21, is issuing a Notice of Intent to execute a Sole Source Award for Courier Specimen Transport Services. This procurement aims to contract with the Regents of the University of California, San Francisco for a base year plus two option years, utilizing simplified acquisition procedures due to the Government's strategic need for restructuring staff and requirements. The services are critical for the efficient transport of specimens, which supports the overall operations of the Veterans Health Administration. Interested parties may direct inquiries to the Contracting Officer, James Postell, at james.postell@va.gov, as no competitive proposals will be solicited at this stage.
Notice of Intent to Sole Source Cost Per Reportable Testing and Lease of MicroScan WalkAway for Naval Medical Center Portsmouth
Buyer not available
The Department of Defense, through the Defense Health Agency, intends to award a sole source Firm-Fixed-Price contract to Beckman Coulter, INC. for the provision of a Cost Per Reportable MicroScan WalkAway system, which includes equipment lease, consumables, and maintenance support. This procurement is critical as the MicroScan WalkAway system is already validated and in use at the Naval Medical Center Portsmouth, ensuring continuity in laboratory operations and avoiding substantial duplication of costs estimated at approximately $300,000 if a new vendor were to be selected. The total estimated value of the contract is $550,348, with a performance period starting from June 1, 2025, to May 31, 2026, and the Government is seeking responses that demonstrate the advantages of competition. Interested parties can direct inquiries to Contract Specialist Lisa Wilk at lisa.c.wilk.civ@health.mil, and should reference "Notice of Intent Question Submission 12215615" in their correspondence.
COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5 and Influenza A/H7 Extraction Reagents
Buyer not available
The Department of Defense, through the Naval Medical Research Center (NMRC), intends to award a sole-source contract to Roche Diagnostics Corporation for the procurement of essential supplies required for COVID-19 and various influenza detection assays. This contract encompasses the purchase of reagents for 1,000 extraction reactions every two months over a total of six shipments, amounting to 6,000 reactions, with a total funding of $52,920 allocated from Navy Fiscal Year 2025 funds. The unique qualifications of Roche Diagnostics necessitate this sole-source acquisition, as their products are the only ones meeting the required diagnostic grade quality, thereby excluding competitive bidding under applicable regulations. Interested parties may contact Shamai Carter at shamai.m.carter.civ@health.mil or Deborah Sharpe at deborah.m.sharpe2.civ@health.mil for further information.
VISN 1 Primary Reference Laboratory Testing
Buyer not available
The Department of Veterans Affairs is seeking contractors to provide primary reference laboratory testing services, including phlebotomy and courier services, for all VISN 1 sites, primarily located in New England. The objective is to enhance healthcare delivery for veterans by ensuring timely and accurate laboratory testing, which is critical for effective patient management and treatment. This opportunity is part of a broader initiative to improve healthcare services within the Veterans Health Administration, with a focus on compliance with federal regulations and quality assurance standards. Interested parties must submit their responses by May 9, 2025, at 4:00 PM EST, to Cynthia Thompson at cynthia.thompson2@va.gov, and are encouraged to review the detailed requirements outlined in the Performance Work Statement and associated documents.
6505--Intent to Sole Source Transfusion Services and Blood Products FARGO VA Health Care System
Buyer not available
The Department of Veterans Affairs, specifically the Fargo VA Health Care System, intends to establish a Sole Source contract for Transfusion Services and Blood Products, focusing on a single supplier within a 30-mile radius to ensure timely delivery. The contract, which will span from October 1, 2025, to September 30, 2030, includes a base year and four one-year options, requiring the contractor to provide blood components that meet FDA and AABB standards, along with reference testing services and emergency support. This procurement is critical for maintaining the health and safety of veterans, ensuring that blood products are readily available and compliant with stringent regulations. Interested parties must submit their responses by May 13, 2025, to Alberta Mickells at Alberta.Mickells@va.gov, as the government will proceed with a sole source acquisition if no competitive responses are received.
Molecular Diagnostics Analyzer and Reagents for detection of the Antibodies and Pathogens
Buyer not available
The Department of Defense, specifically the Department of the Army, is seeking sources for a contract to provide a Molecular Diagnostics Analyzer and Reagents for the detection of antibodies and pathogens, including Herpes simplex virus (HSV 1 and 2), congenital cytomegalovirus (CMV), Candida auris, and Varicella Zoster Virus (VZV). The procurement aims to enhance diagnostic capabilities at the Joint Base Lewis McChord Health Contracting Branch by acquiring FDA-approved systems that can perform qualitative nucleic acid amplification testing (NAAT) with rapid results and minimal downtime. This initiative is critical for improving patient care and operational efficiency in public health laboratories. Interested parties are encouraged to submit their capabilities statements and relevant information to Cindy Means at cindy.j.means.civ@health.mil by the specified deadline, as this sources sought notice is for market research purposes and does not constitute a formal solicitation.